These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28943146)

  • 1. Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study.
    Fam JM; Felix C; Ishibashi Y; Onuma Y; Diletti R; Van Mieghem NM; Regar E; De Jaegere P; Zijlstra F; van Geuns RJM
    Int J Cardiol; 2017 Dec; 249():119-126. PubMed ID: 28943146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Ortega-Paz L; Capodanno D; Giacchi G; Gori T; Nef H; Latib A; Caramanno G; Di Mario C; Naber C; Lesiak M; Capranzano P; Wiebe J; Mehilli J; Araszkiewicz A; Pyxaras S; Mattesini A; Geraci S; Naganuma T; Colombo A; Münzel T; Sabaté M; Tamburino C; Brugaletta S
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):812-818. PubMed ID: 27515568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.
    Hemetsberger R; Abdelghani M; Mankerious N; Allali A; Toelg R; Gori T; Achenbach S; Riemer T; Mehilli J; Nef HM; Naber C; Wöhrle J; Zahn R; Kastner J; Schmermund A; Hamm C; Münzel T; Richardt G;
    Coron Artery Dis; 2020 Nov; 31(7):578-585. PubMed ID: 32271247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).
    Tarantini G; Masiero G; Fovino LN; Mojoli M; Varricchio A; Loi B; Gistri R; Misuraca L; Gabrielli G; Cortese B; Pisano F; Moretti L; Tumminello G; Olivari Z; Mazzarotto P; Colombo A; Calabrò P; Nicolino A; Tellaroli P; Corrado D; Durante A; Steffenino G;
    Int J Cardiol; 2018 Sep; 266():67-74. PubMed ID: 29887475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
    Serruys PW; Chevalier B; Dudek D; Cequier A; Carrié D; Iniguez A; Dominici M; van der Schaaf RJ; Haude M; Wasungu L; Veldhof S; Peng L; Staehr P; Grundeken MJ; Ishibashi Y; Garcia-Garcia HM; Onuma Y
    Lancet; 2015 Jan; 385(9962):43-54. PubMed ID: 25230593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).
    Biscaglia S; Ugo F; Ielasi A; Secco GG; Durante A; D'Ascenzo F; Cerrato E; Balghith M; Pasquetto G; Penzo C; Fineschi M; Bonechi F; Templin C; Menozzi M; Aquilina M; Rognoni A; Capasso P; Di Mario C; Brugaletta S; Campo G
    Int J Cardiol; 2016 Apr; 208():40-5. PubMed ID: 26826788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.
    Wiebe J; Dörr O; Bauer T; Liebetrau C; Boeder N; Möllmann H; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2016; 17(5):313-7. PubMed ID: 27085220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes.
    Regazzoli D; Latib A; Ezhumalai B; Tanaka A; Leone PP; Khan S; Kumar V; Rastogi V; Ancona MB; Mangieri A; Giannini F; Mitomo S; Seth A; Colombo A
    Int J Cardiol; 2018 Nov; 270():113-117. PubMed ID: 29983253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds.
    Panoulas VF; Miyazaki T; Sato K; Naganuma T; Sticchi A; Kawamoto H; Figini F; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    EuroIntervention; 2016 Mar; 11(12):1355-62. PubMed ID: 25868742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.
    Gao R; Yang Y; Han Y; Huo Y; Chen J; Yu B; Su X; Li L; Kuo HC; Ying SW; Cheong WF; Zhang Y; Su X; Xu B; Popma JJ; Stone GW;
    J Am Coll Cardiol; 2015 Dec; 66(21):2298-2309. PubMed ID: 26471805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery perforation and acute scaffold thrombosis after bioresorbable vascular scaffold implantation for a calcified lesion.
    Lee WC; Fang HY; Wu CJ
    Int J Cardiol; 2016 Nov; 222():620-621. PubMed ID: 27517650
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial.
    Abdel-Wahab M; Richardt G; Joachim Büttner H; Toelg R; Geist V; Meinertz T; Schofer J; King L; Neumann FJ; Khattab AA
    JACC Cardiovasc Interv; 2013 Jan; 6(1):10-9. PubMed ID: 23266232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.
    Armstrong EJ; Stanislawski MA; Kokkinidis DG; Plomondon ME; Barón AE; Giri J; Shunk KA; Banerjee S; Maddox TM; Waldo SW
    Catheter Cardiovasc Interv; 2018 May; 91(6):1009-1017. PubMed ID: 28766833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
    Diletti R; Farooq V; Girasis C; Bourantas C; Onuma Y; Heo JH; Gogas BD; van Geuns RJ; Regar E; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn RJ; Smits P; Koolen J; Meredith I; Li X; Miquel-Hebert K; Veldhof S; Garcia-Garcia HM; Ormiston JA; Serruys PW
    Heart; 2013 Jan; 99(2):98-105. PubMed ID: 23118346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.